1. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE). Issue 6 (24th May 2018) Authors: Kappos, Ludwig; Wolinsky, Jerry S; Giovannoni, Gavin; Arnold, Douglas L; Lublin, Fred; Wang, Qing; Model, Fabian; Wei, Wei; Garren, Hideki; Manfrini, Marianna; Belachew, Shibeshih; Hauser, Stephen Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?. Issue 1 (January 2019) Authors: Lee, Lisa Eunyoung; Chan, Jillian K; Nevill, Emilie; Soares, Adam; Vavasour, Irene M; MacMillan, Erin L; Garren, Hideki; Clayton, David; Keegan, B Mark; Tam, Roger; Traboulsee, Anthony L; Kolind, Shannon H; Carruthers, Robert L Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 5:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial. Issue 4 (16th October 2018) Authors: Wolinsky, Jerry S.; Montalban, Xavier; Hauser, Stephen L.; Giovannoni, Gavin; Vermersch, Patrick; Bernasconi, Corrado; Deol‐Bhullar, Gurpreet; Garren, Hideki; Chin, Peter; Belachew, Shibeshih; Kappos, Ludwig Journal: Annals of neurology Issue: Volume 84:Issue 4(2018) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial. Issue 5 (8th May 2017) Authors: Wolinsky, Jerry; Montalban, Xavier; Kappos, Ludwig; Hauser, Stephen; Giovannoni, Gavin; Seze, Jerome de; Bar-Or, Amit; Masterman, Donna; Bernasconi, Corrado; Wei, Wei; Garren, Hideki; Chin, Peter; Belachew, Shibeshih; Arnold, Doug L Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88:Issue 5(2017) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a. Issue 4 (October 2019) Authors: MacMillan, Erin L; Schubert, Julia J; Vavasour, Irene M; Tam, Roger; Rauscher, Alexander; Taylor, Carolyn; White, Rick; Garren, Hideki; Clayton, David; Levesque, Victoria; Li, David KB; Kolind, Shannon H; Traboulsee, Anthony L Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 5:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Issue 1 (March 2018) Authors: Havrdová, Eva; Arnold, Douglas L; Bar-Or, Amit; Comi, Giancarlo; Hartung, Hans-Peter; Kappos, Ludwig; Lublin, Fred; Selmaj, Krzysztof; Traboulsee, Anthony; Belachew, Shibeshih; Bennett, Iain; Buffels, Regine; Garren, Hideki; Han, Jian; Julian, Laura; Napieralski, Julie; Hauser, Stephen L; Giovann... Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO127 Composite confirmed disability progression in oratorio. (1st December 2017) Authors: Giovannoni, Gavin; Arnold, Douglas L; Bar-Or, Amit; Seze, Jérôme de; Hemmer, Bernhard; Montalban, Xavier; Belachew, Shibeshih; Bernasconi, Corrado; Garren, Hideki; Wolinsky, Jerry Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88(2017)Supplement 1 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Preliminary results of the opera i and opera ii open-label extension study. Issue 5 (8th May 2017) Authors: Naismith, Robert; Cascione, Mark; Grimaldi, Luigi; Hauser, Stephen; Kappos, Ludwig; Montalban, Xavier; Wolinsky, Jerry; Chin, Peter; Garren, Hideki; Julian, Laura; Model, Fabian; Honeycutt, David Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88:Issue 5(2017) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis. Issue 7 (15th January 2019) Authors: O'Muircheartaigh, Jonathan; Vavasour, Irene; Ljungberg, Emil; Li, David K. B.; Rauscher, Alexander; Levesque, Victoria; Garren, Hideki; Clayton, David; Tam, Roger; Traboulsee, Anthony; Kolind, Shannon Journal: Human brain mapping Issue: Volume 40:Issue 7(2019) Page Start: 2104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. Issue 5 (May 2020) Authors: Traboulsee, Anthony; Greenberg, Benjamin M; Bennett, Jeffrey L; Szczechowski, Lech; Fox, Edward; Shkrobot, Svitlana; Yamamura, Takashi; Terada, Yusuke; Kawata, Yuichi; Wright, Padraig; Gianella-Borradori, Athos; Garren, Hideki; Weinshenker, Brian G Journal: Lancet neurology Issue: Volume 19:Issue 5(2020) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗